AnalystsInsight

Daniel Imbro (Stephens): Analyst Track Record and Price‑Target Accuracy

How often Daniel Imbro’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 400 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#613 rank (was #660)4.8★ rating (was 4.7★)

Key takeaways

  • Daniel Imbro ranks #583 of 1,000 analysts in Exent’s scoring (4.8★).
  • 50.0% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 97 days; 67.8% of calls were up 12 months later.
  • Most‑covered stocks: CVNA, CALY, AAP, DORM.
  • Free on Exent: Daniel Imbro’s full record, with ratings 3 days after publication.

Daniel Imbro’s track record at a glance

Daniel Imbro of Stephens ranks #583 of the 1,000 analysts Exent scores, with a 4.8★ rating and a focus on industrials. Over a 7‑year lookback, 50.0% of Daniel’s price targets were reached, 2.4 points below the 52.4% average across all analysts.

MetricDaniel ImbroAll analysts
Price‑target hit rate50.0%52.4%
Median days to hit target97 days91 days
Calls up after 12 months67.8%64.0%
Median 12‑month return of calls+16.7%+13.4%
Hit rate, last 2 years72.7%—
Average worst drop after a call−21.5%—
Ratings in the sample400—
Stocks covered49—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetDaniel Imbro
Under 30 days18.9%
30–90 days26.7%
90–180 days23.3%
Over 180 days31.1%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Daniel Imbro covers most

StockRatings in the sample
CVNA20
CALY15
AAP15
DORM15
PAMT14
AZO14
FDX13
RUSHA13

In the past year Daniel’s ratings were 100% Buy, 0% Hold and 0% Sell.

Daniel Imbro’s latest ratings

DateStockActionRatingPrice target
Jan 16, 2026JBHTMaintained: BuyBuy$235.00
Jan 16, 2026JBHTReiterated: BuyBuy$235.00
Jan 16, 2026JBHTMaintainedBuy$235.00
Oct 30, 2025CHRWUpgradedHold → Buy$173.00
Oct 30, 2025CHRWUpgraded: BuyBuy$173.00
Oct 16, 2025JBHTMaintained: BuyBuy$180.00
Oct 16, 2025JBHTReiterated: BuyBuy$180.00
Oct 16, 2025JBHTMaintainedBuy$180.00
Oct 14, 2025FDXInitiated Coverage: BuyBuy$260.00
Oct 14, 2025FDXInitiated CoverageBuy$260.00
Aug 4, 2025WERNMaintained: HoldHold$23.00
Aug 4, 2025RUSHAReiterated: BuyBuy$60.00
  • Jan 16, 2026
    Stock
    JBHT
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $235.00
  • Jan 16, 2026
    Stock
    JBHT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $235.00
  • Jan 16, 2026
    Stock
    JBHT
    Action
    Maintained
    Rating
    Buy
    Price target
    $235.00
  • Oct 30, 2025
    Stock
    CHRW
    Action
    Upgraded
    Rating
    Hold → Buy
    Price target
    $173.00
  • Oct 30, 2025
    Stock
    CHRW
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $173.00
  • Oct 16, 2025
    Stock
    JBHT
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $180.00
  • Oct 16, 2025
    Stock
    JBHT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $180.00
  • Oct 16, 2025
    Stock
    JBHT
    Action
    Maintained
    Rating
    Buy
    Price target
    $180.00
  • Oct 14, 2025
    Stock
    FDX
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $260.00
  • Oct 14, 2025
    Stock
    FDX
    Action
    Initiated Coverage
    Rating
    Buy
    Price target
    $260.00
  • Aug 4, 2025
    Stock
    WERN
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $23.00
  • Aug 4, 2025
    Stock
    RUSHA
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $60.00

Daniel’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Daniel Imbro’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Daniel Imbro ranks #583 of 1,000 with a 4.8★ rating. 50.0% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 67.8% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Daniel Imbro’s success rate is 69.0% by the ranking source and 50.0% by Exent’s price-target hit-rate backtest, with a median of 97 days to reach a target.

Daniel Imbro (Stephens) covers 49 stocks, mostly in industrials. The most frequently rated are CVNA, CALY, AAP, DORM, PAMT.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.